Abstract:Objective To investigate the expression and significance of SOX-2, SOX-10 and GDNF in the different intestinal tracts of children with congenital megacolon disease (HD).Methods Seleced 85 cases of HD children in our hospital from January 2014 to August 2019 who underwent surgical treatment as the observation group, of which the intestinal canal tissues of the narrowed, lated, and transitional segments were removed for experiment. At the same time, 20 cases of children undergoing colostomy were used as the control group. The fluorescent quantitative PCR was used to detect the mRNA levels of the SOX-2, the SOX-10, and the GDNF in the intestinal tissue.Results The diameter of myenteric nerve plexus, ganglion cell diameter, ganglion cell number, ganglion cytoplasm/nucleus ratio were compared in each group, and the difference was statistically significant after analysis of variance (all P < 0.05). Among them, the diameter of the intestinal myenteric plexus: HD group stenosis segment < HD group transitional segment < HD group expansion segment and control group; ganglion cell diameter, ganglion cell number, ganglion cytoplasm/nucleus ratio: HD group transitional segment < HD The expansion segment of the group and the control group. Comparison of the relative expression of SOX-2, SOX-10, GDNF at the mRNA level of each group showed statistically significant differences (P < 0.05). Among them, the relative expression of SOX-2, SOX-10, and GDNF at the mRNA level: stenosis segment in HD group < transition segment in case group < expanded segment in HD group, and the difference was statistically significant (P < 0.05). There was no significant difference between the control group and the HD group in the expansion segment (P > 0.05).Conclusion The expression levels of SOX-2, SOX-10, and GDNF in the pathological bowel tissues of HD children were gradually reduced in the dilatation segment, transitional segment, and stenosis segment, which were related to abnormal development of the pathological bowel nervous system.